Partial protection against H5N1 influenza in mice with a single dose of a chimpanzee adenovirus vector expressing nucleoprotein

Vaccine

Volumn 25, Issue 39-40, 2007, Pages 6845-6851

  Roy, Soumitra ^a   Kobinger, Gary P ^b   Lin, Jianping ^a   Figueredo, Joanita ^a   Calcedo, Roberto ^a   Kobasa, Darwyn ^b   Wilson, James M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

Adenovirus vector; Chimpanzee adenovirus; Influenza vaccine; Nucleoprotein

Indexed keywords

ADENOVIRUS VECTOR; EPITOPE; INFLUENZA VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; THREONYLTYROSYLGLUTAMINYLARGINYLTHREONYLARGINYLALANYLLEUCYLVALINE; UNCLASSIFIED DRUG; VIRUS NUCLEOPROTEIN;

ADENOVIRUS; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; CELLULAR IMMUNITY; CHIMPANZEE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOLYSIS; DRUG EFFICACY; ENDEMIC DISEASE; EPIDEMIC; EXPERIMENTAL MOUSE; EXPRESSION VECTOR; FOWL; HUMAN; HUMAN CELL; INFLUENZA; INFLUENZA VIRUS A H5N1; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUERTO RICO; SEQUENCE ANALYSIS; SEROTYPE; STATISTICAL SIGNIFICANCE; STRAIN DIFFERENCE; SURVIVAL; T LYMPHOCYTE ACTIVATION; VIET NAM; VIRAL GENE DELIVERY SYSTEM; VIRUS STRAIN; VIRUS TYPING;

ADENOVIRUSES, HUMAN; AMINO ACID SEQUENCE; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; GENETIC VECTORS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NUCLEOPROTEINS; ORTHOMYXOVIRIDAE INFECTIONS; PAN TROGLODYTES; RNA-BINDING PROTEINS; T-LYMPHOCYTES; VIRAL CORE PROTEINS;

EID: 34548657274     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.07.035     Document Type: Article

References (25)

1. Kaiser J. A one-size-fits-all flu vaccine?. Science 312 5772 (2006) 380-382
2. Townsend A.R., McMichael A.J., Carter N.P., Huddleston J.A., and Brownlee G.G. Cytotoxic T cell recognition of the influenza nucleoprotein and hemagglutinin expressed in transfected mouse L cells. Cell 39 1 (1984) 13-25
3. Yewdell J.W., Bennink J.R., Smith G.L., and Moss B. Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes. PNAS 82 6 (1985) 1785-1789
4. + T lymphocytes. J Immunol 172 4 (2004) 2453-2460
5. Gorman O.T., Bean W.J., Kawaoka Y., Donatelli I., Guo Y.J., and Webster R.G. Evolution of influenza A virus nucleoprotein genes: implications for the origins of H1N1 human and classical swine viruses. J Virol 65 7 (1991) 3704-3714
6. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259 5102 (1993) 1745-1749 [see comment]
7. + T cells against influenza virus induced by vaccination with nucleoprotein DNA. J Virol 72 7 (1998) 5648-5653
8. Epstein S.L., Kong W.P., Misplon J.A., Lo C.Y., Tumpey T.M., Xu L., et al. Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein. Vaccine 23 46-47 (2005) 5404-5410
9. Kremer E.J., Boutin S., Chillon M., and Danos O. Canine adenovirus vectors: an alternative for adenovirus-mediated gene transfer. J Virol 74 1 (2000) 505-512
10. Mittal S.K., Middleton D.M., Tikoo S.K., and Babiuk L.A. Pathogenesis and immunogenicity of bovine adenovirus type 3 in cotton rats (Sigmodon hispidus). Virology 213 1 (1995) 131-139
11. Roy S., Gao G., Lu Y., Zhou X., Lock M., Calcedo R., et al. Characterization of a family of chimpanzee adenoviruses and development of molecular clones for gene transfer vectors. Hum Gene Ther 15 5 (2004) 519-530
12. Xu Z.Z., Hyatt A., Boyle D.B., and Both G.W. Construction of ovine adenovirus recombinants by gene insertion or deletion of related terminal region sequences. Virology 230 1 (1997) 62-71
13. Kobinger G.P., Feldmann H., Zhi Y., Schumer G., Gao G., Feldmann F., et al. Chimpanzee adenovirus vaccine protects against Zaire Ebola virus. Virology 346 2 (2006) 394-401
14. Zhi Y., Figueredo J., Kobinger G.P., Hagan H., Calcedo R., Miller J.R., et al. Efficacy of severe acute respiratory syndrome vaccine based on a nonhuman primate adenovirus in the presence of immunity against human adenovirus. Hum Gene Ther 17 5 (2006) 500-506
15. Reyes-Sandoval A., Fitzgerald J.C., Grant R., Roy S., Xiang Z.Q., Li Y., et al. Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes. J Virol 78 14 (2004) 7392-7399
16. Tatsis N., Tesema L., Robinson E.R., Giles-Davis W., McCoy K., Gao G.P., et al. Chimpanzee-origin adenovirus vectors as vaccine carriers. Gene Ther 13 5 (2006) 421-429
17. Roy S., Zhi Y., Kobinger G.P., Figueredo J., Calcedo R., Miller J.R., et al. Generation of an adenoviral vaccine vector based on simian adenovirus 21. J Gen Virol 87 Pt 9 (2006) 2477-2485
18. Rotzschke O., Falk K., Deres K., Schild H., Norda M., Metzger J., et al. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature 348 6298 (1990) 252-254
19. van der Most R.G., Harrington L.E., Giuggio V., Mahar P.L., and Ahmed R. Yellow fever virus 17D envelope and NS3 proteins are major targets of the antiviral T cell response in mice. Virology 296 1 (2002) 117-124
20. Makedonas G., and Betts M.R. Polyfunctional analysis of human T cell responses: importance in vaccine immunogenicity and natural infection. Springer Semin Immunopathol 28 3 (2006) 209-219
21. Harari A., Dutoit V., Cellerai C., Bart P.A., Du Pasquier R.A., and Pantaleo G. Functional signatures of protective antiviral T-cell immunity in human virus infections. Immunol Rev 211 (2006) 236-254
22. Andrew M.E., Coupar B.E., Boyle D.B., and Ada G.L. The roles of influenza virus haemagglutinin and nucleoprotein in protection: analysis using vaccinia virus recombinants. Scand J Immunol 25 1 (1987) 21-28
23. Webster R.G., Kawaoka Y., Taylor J., Weinberg R., and Paoletti E. Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens. Vaccine 9 5 (1991) 303-308
24. Macklin M.D., McCabe D., McGregor M.W., Neumann V., Meyer T., Callan R., et al. Immunization of pigs with a particle-mediated DNA vaccine to influenza A virus protects against challenge with homologous virus. J Virol 72 2 (1998) 1491-1496
25. Wesley R.D., Tang M., and Lager K.M. Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus. Vaccine 22 25-26 (2004) 3427-3434